Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Anheuser Busch Inbev ADR Rep 1 Ord Shs BUD

Anheuser-Busch Inbev SA is a Belgium-based company. The Company is primarily engaged in the manufacturing of beer. The Company operates through six segments: North America, Middle Americas, South America, EMEA, Asia Pacific, Global Export and Holding companies. The Company's brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck... see more

NYSE:BUD - Post Discussion

Anheuser Busch Inbev ADR Rep 1 Ord Shs > Incredible Value. ENTG at about 25% of One Years Revenue
View:
Post by Wrywisdom on Aug 10, 2022 3:22pm

Incredible Value. ENTG at about 25% of One Years Revenue

.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:

                   https://stockhouse.com/news/press-releases/2022/05/30/entourage-health-reports-record-first-quarter-2022-financial-results

Notwithstanding all of the prior major achievements getting us to this point, just within the past few weeks:

           -unlike so many cannabis counterparts, ENTG has shored up high level financing guaranteed for more than 2 years with no dilution, and dramatically reduces convertible debentures:

                   https://stockhouse.com/news/press-releases/2022/07/29/entourage-health-provides-update-on-credit-facilities-maturity-dates-and-amends

           -Further expands medical offerings with new products and services:

                   tockhouse.com/news/press-releases/2022/07/26/entourage-expands-medical-offerings-with-launch-of-new-services-and-products

          -Announces and exclusive Canadian licensing deal to distribute a broad range of Irwin Naturals cannabis Products:

                   https://stockhouse.com/news/press-releases/2022/08/04/irwin-naturals-cannabis-products-to-be-available-in-canada

          
...and will be introducting groundbreaking Boston Beer/Samuel Adams products at any time now:
            https://stockhouse.com/news/press-releases/2022/05/23/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced

         
Simply an unrivaled value, period. 
What a truly extraordinary opportunity here particularly for new investors but again, also for those seeking to cost average as well.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities